CYTK — Cytokinetics, Incorporated Share News
0.000.00%
Last trade - 00:00- $8.89bn
- $8.87bn
- $88.04m
U.S. STOCKS ON THE MOVE-Nvidia, Eli Lilly, Manchester United
Cytokinetics rises after upsized $650 mln convertible bonds sale
Brief: Cytokinetics Inc Prices Its Offering Of $650.0 Million Aggregate Principal Amount Of 1.75% Convertible Senior Notes Due 2031
Cytokinetics falls after announcing $550 mln convertible bonds offering
Brief: Cytokinetics Participates In FDA Late Cycle Meeting For NDA For Aficamten - SEC Filing
Brief: Cytokinetics Announces Proposed Private Placement Of $550.0 Million
U.S. STOCKS ON THE MOVE-Cytokinetics, Air Lease Corp, Lyft Inc
Cytokinetics says heart disease drug more effective than standard-of-care, shares jump
U.S. STOCKS ON THE MOVE-United Therapeutics, Signet Jewelers, Arrowhead
U.S. STOCKS ON THE MOVE-PepsiCo, Ionis Pharma, United Therapeutics
U.S. STOCKS ON THE MOVE-Gold miners, Zscaler, SailPoint
Cytokinetics says heart disease drug more effective than standard-of-care, shares jump
U.S. RESEARCH ROUNDUP-Fortinet, Sailpoint, Zscaler
Cytokinetics' drug more effective for heart disease symptoms than standard-of-care
Brief: Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Cytokinetics rises as investors await US approval for heart drug
Cytokinetics Inc reports results for the quarter ended June 30 - Earnings Summary
Biopharma firm Cytokinetics Q2 revenue jumps
Brief: Cytokinetics To Announce Second Quarter Results On August 7, 2025